Published in J Neurosci on November 25, 2009
Imaging genomics. Curr Opin Neurol (2010) 1.31
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology (2010) 1.29
Connectomic intermediate phenotypes for psychiatric disorders. Front Psychiatry (2012) 1.26
Understanding resilience. Front Behav Neurosci (2013) 1.19
Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology (2011) 1.13
DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Proc Natl Acad Sci U S A (2010) 1.11
DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding. Schizophr Bull (2011) 0.98
Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Transl Psychiatry (2013) 0.94
DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex (2012) 0.92
Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophr Bull (2015) 0.91
mRNA transcript diversity creates new opportunities for pharmacological intervention. Mol Pharmacol (2012) 0.89
The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet (2013) 0.86
The amygdala: inside and out. F1000 Biol Rep (2011) 0.85
Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain. Front Mol Neurosci (2011) 0.84
A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Mol Psychiatry (2015) 0.83
Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2. Front Behav Neurosci (2014) 0.82
Implicit processing of visual emotions is affected by sound-induced affective states and individual affective traits. PLoS One (2014) 0.80
FXR1P is a GSK3β substrate regulating mood and emotion processing. Proc Natl Acad Sci U S A (2015) 0.80
The genetics of anxiety-related negative valence system traits. Am J Med Genet B Neuropsychiatr Genet (2016) 0.79
BDNF rs6265 methylation and genotype interact on risk for schizophrenia. Epigenetics (2016) 0.78
Preliminary investigation of the influence of dopamine regulating genes on social working memory. Soc Neurosci (2014) 0.78
Association between amygdala reactivity and a dopamine transporter gene polymorphism. Transl Psychiatry (2014) 0.78
The associations among the dopamine D2 receptor Taq1, emotional intelligence, creative potential measured by divergent thinking, and motivational state and these associations' sex differences. Front Psychol (2015) 0.77
The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations. Transl Psychiatry (2015) 0.76
Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2). Brain Imaging Behav (2015) 0.76
DAT by perceived MC interaction on human prefrontal activity and connectivity during emotion processing. Soc Cogn Affect Neurosci (2012) 0.76
The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76
Facial affect processing deficits in schizophrenia: a meta-analysis of antipsychotic treatment effects. J Psychopharmacol (2014) 0.75
Association between Ability Emotional Intelligence and Left Insula during Social Judgment of Facial Emotions. PLoS One (2016) 0.75
The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia (1971) 86.03
Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci U S A (2001) 14.86
The cognitive control of emotion. Trends Cogn Sci (2005) 14.58
The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Res (2009) 11.53
For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage (2004) 8.72
Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry (2003) 6.93
The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol (2004) 5.66
Validation of the five-factor model of personality across instruments and observers. J Pers Soc Psychol (1987) 4.68
Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport (2000) 4.50
Reflecting upon feelings: an fMRI study of neural systems supporting the attribution of emotion to self and other. J Cogn Neurosci (2004) 4.37
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99
Emotion, cognition, and behavior. Science (2002) 3.83
Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A (2006) 3.58
Fear and the brain: where have we been, and where are we going? Biol Psychiatry (1998) 2.89
Neural mechanisms of a genome-wide supported psychosis variant. Science (2009) 2.88
Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet (1997) 2.88
Distinct functions of the two isoforms of dopamine D2 receptors. Nature (2000) 2.83
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A (2007) 2.62
A validated network of effective amygdala connectivity. Neuroimage (2007) 2.58
Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol (2004) 2.38
Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci (2005) 2.37
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A (1993) 2.10
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
Heritability of the big five personality dimensions and their facets: a twin study. J Pers (1996) 1.99
Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry (2006) 1.94
Heritability of facet-level traits in a cross-cultural twin sample: support for a hierarchical model of personality. J Pers Soc Psychol (1998) 1.91
Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci (2007) 1.66
Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci (2001) 1.64
Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet (2003) 1.64
Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry (2005) 1.55
Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves. Biotechniques (2003) 1.53
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry (2004) 1.51
Mode of functional connectivity in amygdala pathways dissociates level of awareness for signals of fear. J Neurosci (2006) 1.46
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain (2008) 1.37
The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage (2008) 1.22
COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology (2005) 1.21
Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res (2001) 1.20
Neural connectivity as an intermediate phenotype: brain networks under genetic control. Hum Brain Mapp (2009) 1.19
Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci (2009) 1.18
The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav Neurosci (2000) 1.17
A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology (2007) 1.17
Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol (2005) 1.15
Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link? Eur J Pharmacol (2005) 1.05
Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol Psychiatry (2008) 0.98
Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry (2002) 0.96
Activity in medial prefrontal cortex during cognitive evaluation of threatening stimuli as a function of personality style. Brain Res Bull (2007) 0.89
D2-like dopamine receptor mediation of social-emotional reactivity in a mouse model of anxiety: strain and experience effects. Neuropsychopharmacology (1998) 0.84
Emotional response in dopamine D2L receptor-deficient mice. Behav Brain Res (2008) 0.82
Amphetamine psychosis: clinical presentations and differential diagnosis. Psychiatr Med (1988) 0.80
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Strategies and methods for research on sex differences in brain and behavior. Endocrinology (2004) 5.02
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res (2005) 3.52
MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther (2008) 3.06
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A (2007) 2.62
MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther (2007) 2.53
Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry (2003) 2.47
Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others. Cleve Clin J Med (2011) 2.43
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci (2005) 2.37
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med (2009) 2.37
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A (2004) 2.36
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res (2004) 2.10
Independent component model of the default-mode brain function: Assessing the impact of active thinking. Brain Res Bull (2006) 1.99
Innate immune gene polymorphisms in tuberculosis. Infect Immun (2012) 1.89
Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol (2002) 1.87
Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci (2006) 1.85
Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biol Psychiatry (2006) 1.71
Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci (2008) 1.67
Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry (2005) 1.55
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry (2004) 1.51
Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neurosci (2006) 1.51
The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia. Am J Physiol Lung Cell Mol Physiol (2008) 1.45
Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci (2011) 1.41
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenet Genomics (2007) 1.40
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain (2008) 1.37
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol (2006) 1.31
Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia. Neuropsychopharmacology (2009) 1.30
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology (2010) 1.29
Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol Ther (2004) 1.26
Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One (2010) 1.24
Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. Eur J Hum Genet (2010) 1.23
Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk. PLoS One (2012) 1.21
Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci (2009) 1.18
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment. J Pharmacol Exp Ther (2007) 1.16
Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum Mol Genet (2013) 1.16
Protein therapeutics: new applications for pharmacogenetics. Nat Rev Drug Discov (2006) 1.15
Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology (2006) 1.15
Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology (2011) 1.13